Morgan Stanley Valens Company, Inc. Transaction History

Morgan Stanley

$1.35 Trillion
Q3 2024

Shares

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held	SEC Form
Q4 2022 Feb 14, 2023	BUY	$0.64 - $1.02 $76,532 - $121,973	119,582 Added 143.59%	202,861 $133,000
Q3 2022 Nov 14, 2022	BUY	$0.64 - $1.22 $50,718 - $96,681	79,247 Added 1965.45%	83,279 $56,000
Q2 2022 Oct 27, 2022	BUY	$0.61 - $1.69 $360 - $998	591 Added 17.18%	4,032 $2,000
Q2 2022 Aug 15, 2022	BUY	$0.61 - $1.69 $360 - $998	591 Added 17.18%	4,032 $2,000
Q1 2022 Oct 27, 2022	SELL	$1.69 - $2.82 $998 - $1,666	-591 Reduced 14.66%	3,441 $6,000
Q1 2022 May 13, 2022	SELL	$1.69 - $2.82 $16,215 - $27,057	-9,595 Reduced 73.6%	3,441 $6,000
Q4 2021 Feb 14, 2022	BUY	$2.4 - $3.18 $31,286 - $41,454	13,036 New	13,036 $32,000

Others Institutions Holding VLNS

# of Institutions

1

Shares Held

0

Call Options Held

0

Put Options Held

0

Concourse Financial Group Securities, Inc. Birmingham, AL

0
Shares

$0
0.0% of portfolio

About Valens Company, Inc.

Ticker VLNS
Exchange NASDAQ
Description
The Valens Company Inc. develops, manufactures, and sells cannabinoid-based products in Canada and internationally. It produces dried cannabis and hemp biomass products. The company also provides a range of products, including tinctures, two-piece caps, soft gels, oral sprays, and vape pens, as well as beverages, concentrates, topicals, edibles,...

More about VLNS

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Morgan Stanley, based on Form 13F filings with the SEC.

News

Stay updated on Morgan Stanley with notifications on news.